Incorporation of PBRM1, BAP1, TP53 mutation status into the Memorial Sloan Kettering Cancer Center (MSKCC) risk model: A genomically annotated tool to improve stratification of patients (pts) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback